The oversight occurred at Layhill Nursing and Rehabilitation Center when Resident #5 returned from a hospital stay. Federal inspectors found that the facility's pharmacy failed to identify Sirolimus 0.5 mg tablets and Tacrolimus 2 mg capsules during their mandatory medication review process.
Both drugs appeared clearly on the hospital's discharge medication list dated March 11, 2025. The discharge summary specified that the resident should take Sirolimus 0.5 mg tablets every 24 hours and Tacrolimus 2 mg capsules every 24 hours.
Anti-rejection medications serve a life-or-death function for transplant recipients. These immunosuppressants prevent the body's immune system from attacking and rejecting a transplanted organ. Without them, the transplanted organ can fail.
The facility's Director of Nursing acknowledged the error during an October 6 interview with inspectors. She explained that the pharmacy has responsibility for reviewing hospital discharge medication lists and reconciling medications when residents are admitted.
"The pharmacy completed Resident #5's admission medication review however they overlooked the 2 anti-rejection medications," the Director of Nursing told inspectors.
Federal regulations require nursing homes to conduct comprehensive pharmacy medication regimen reviews for all residents. These evaluations assess a patient's complete medication list for safety and effectiveness, identifying potential problems like drug interactions, incorrect dosages, unnecessary drugs, or dangerous side effects.
The review process involves examining medical records and lab reports, typically resulting in a written report to the physician with recommendations for action. The goal is promoting positive outcomes while minimizing risks.
In this case, the pharmacy's admission Medication Review (aMMR) completely missed both immunosuppressant drugs despite their clear listing on the hospital discharge summary.
The resident had been transferred to a local hospital and later readmitted to the nursing facility. Hospital records documented the anti-rejection medication regimen that should have continued uninterrupted.
Inspectors discovered the oversight while reviewing Resident #5's medical records on October 6 at 10:07 AM. They found the hospital discharge summary at 10:19 AM, then examined the facility's pharmacy review at 10:30 AM.
The comparison revealed the stark discrepancy between what the hospital prescribed and what the nursing home's pharmacy identified.
For transplant patients, medication continuity is essential. Any interruption in anti-rejection therapy can trigger the immune system to attack the transplanted organ, potentially leading to organ rejection and failure.
The facility's pharmacy system failed at a critical juncture when the resident was most vulnerable during the transition from hospital to nursing home care.
Federal inspectors classified the violation as causing minimal harm or potential for actual harm, affecting some residents. The finding suggests systemic problems with the facility's medication reconciliation process.
The Director of Nursing's admission that the pharmacy "overlooked" the medications raises questions about the thoroughness of their review procedures and quality control measures.
Transplant recipients require precise medication management throughout their lives. The drugs must be taken consistently and at proper dosages to maintain the delicate balance between preventing rejection and avoiding excessive immunosuppression.
The inspection occurred as part of a complaint investigation on October 9, 2025. The specific nature of the complaint that triggered the federal review was not detailed in the inspection report.
Resident #5's case highlights the vulnerability of nursing home patients who depend on facility staff and contracted services for life-sustaining medications. When systems fail, residents face serious health consequences.
The pharmacy's failure to identify these critical medications during their comprehensive review process represents a breakdown in patient safety protocols designed to protect vulnerable residents during care transitions.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Layhill Nursing and Rehabilitation Center from 2025-10-09 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Layhill Nursing and Rehabilitation Center
- Browse all MD nursing home inspections